✨ 5 results found - Searched 21219 records in 4ms.
Disertasi
Peran MiR-10b, MiR-21, SuPAR dan PAI-1 Sebagai Prediktor Respons Terapi dan Progresivitas pada Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK).
2017 | BY Lyana Setiawan - Noorwati Sutandyo - Siti Boedina Kresno - Rahajuningsih Setiabudy- The Role of MiR-10b, MiR-21, Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), and Plasminogen Activator Inhibitor (PAI)-1 as Predictors of Treatment Response and Progressivity in Non-Small Cell Lung Cancer (NSCLC).
- Nomor Panggil D17020fk
Tesis
Korelasi Antara Asupan Karbohidrat, Protein dan Lemak dengan Kadar C-Reactive Protein: Fokus pada Pasien Kanker Paru Stadium IIIB -IV
2017 | BY Diana Sunardi - Noorwati Sutandyo - Patricia Amanda- Correlation Between Carbohydate, Protein and Fat Intake with Serum C-Reactive Protein Level in Lung Cancer Patients Stage IIIB - IV.
- Nomor Panggil T17141fk
Tesis
Analisis ekspresi miR-10b-5p dan miR-320b pada Vesikel Ekstraseluler dari plasma pasien kanker paru jenis karsinoma bukan sel kecil serta kaitannya dengan kebiasaan merokok
2023 | BY Noorwati Sutandyo - Markus Yovian Widjaja Lomanto - Septelia Inawati Wanandi - Aida S. D. Suriadiredja- Analysis of miR-10b-5p and miR-320b expressions in plasma Extracellular Vesicles of non-small cell lung cancer patients associated with smoking.
- Nomor Panggil T23068fk
Tesis
Ekspresi myomiR– 206 pada pasien kanker paru dengan kaheksia dan kaitannya dengan IL–6
2017 | BY Agus Rahmadi - Noorwati Sutandyo - Puspita Eka Wuyung- Expression of myomiR-206 in lung cancer patient with cachexia in correlation with IL-6.
- Nomor Panggil T17046fk
Tesis
Perbandingan rejimen kemoterapi cisplatin-etoposide dengan cisplatin-docetaxel dalam hal kesintasan 2 tahun dan progression-free survivalpasien kanker paru stadium lanjut jenis non-small cell
2012 | BY Salman Paris Harahap - Noorwati Sutandyo - Cleopas Martin Rumende - Hamzah Shatri- Comparison of chemotherapy effect between cisplatin-etoposide and cisplatin-docetaxed in 2-year survival rate and progression free survival rate of advanced non-small cell lung cancer patients.
- Nomor Panggil T12376fk